Ticagrelor stopped working to unseat clopidogrel as the guideline-recommended P2Y12 inhibitor of option in patients undergoing elective percutaneous coronary intervention for stable CAD in the randomized ALPHEUS trial. Medscape Medical News
Find Out More
